28.05.2015 MediClin AG  DE0006595101

DGAP-News: Election to the Supervisory Board of MEDICLIN Aktiengesellschaft


 
DGAP-News: MediClin AG / Key word(s): Change of Personnel Election to the Supervisory Board of MEDICLIN Aktiengesellschaft 28.05.2015 / 18:33 --------------------------------------------------------------------- Election to the Supervisory Board of MEDICLIN Aktiengesellschaft Offenburg, May 28, 2015. In the context of the ordinary Annual General Meeting of MEDICLIN Aktiengesellschaft the shareholder representatives of the Supervisory Board were elected today in Frankfurt am Main. The Supervisory Board of MEDICLIN Aktiengesellschaft is composed of six employee representatives and of six shareholder representatives. Elected to the Supervisory Board were Dr. Ulrich Wandschneider, Managing Director of Asklepios Kliniken Gesellschaft mit beschränkter Haftung and Chairman of the Corporate Management of the Asklepios Group, Michael Bock, Managing Director of REALKAPITAL Vermögensmanagement GmbH, Dr. Bernard große Broermann, entrepreneur and lawyer, Irmtraut Gürkan, Business Director and Vice Chairwoman of Universitätsklinikum Heidelberg, Rainer Laufs, Independent Business Consultant, Stephan Leonhard, Managing Director of Asklepios Kliniken Gesellschaft mit beschränkter Haftung and Vice Chairman of the Corporate Management of the Asklepios Group. Dr. Ulrich Wandschneider was elected Chairman of the Supervisory Board in the Supervisory Board Meeting which took place after the Annual General Meeting. About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 8 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,900 employees. MediClin ─ a company of the Asklepios Group. --------------------------------------------------------------------- 28.05.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MediClin AG Okenstraße 27 77652 Offenburg Germany Phone: +49 (0)781 488-189 Fax: +49 (0)781 488-184 E-mail: [email protected] Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 362939 28.05.2015


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 609,08 645,11 673,09 659,86 673,14 704,70 730,07
EBITDA1,2 27,01 37,35 93,58 77,50 85,22 90,92 98,73
EBITDA-Marge3 4,43 5,79 13,90 11,74 12,66 12,90
EBIT1,4 6,62 15,06 22,41 0,15 11,56 19,52 12,72
EBIT-Marge5 1,09 2,33 3,33 0,02 1,72 2,77 1,74
Jahresüberschuss1 3,96 7,76 9,68 -0,04 1,49 9,72 -10,72
Netto-Marge6 0,65 1,20 1,44 -0,01 0,22 1,38 -1,47
Cashflow1,7 19,34 29,77 69,59 118,69 81,97 34,64 78,00
Ergebnis je Aktie8 0,08 0,16 0,20 -0,19 0,03 0,20 -0,23
Dividende8 0,05 0,05 0,05 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Mediclin
WKN Kurs in € Einschätzung Börsenwert in Mio. €
659510 2,560 Halten 121,60
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
9,85 19,18 0,51 19,25
KBV KCV KUV EV/EBITDA
0,62 1,56 0,17 1,43
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 06.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
02.05.2024 31.07.2024 04.11.2024 26.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-1,04% -7,04% -6,57% -22,42%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MediClin AG  ISIN: DE0006595101 können Sie bei EQS abrufen


Pflegeeinrichtungen , 659510 , MED , XETR:MED